Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL712920

Cn1ccnc1COc1cc(OCc2cccc(Oc3ccccc3)c2)cc(-c2nc3cccnc3[nH]2)c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
PPARG P37231 5/20 0.38
FFAR1 O14842 7/20 0.37
FFAR4 Q5NUL3 2/20 0.37
NOS1 P29475 1/20 0.35
KIT P10721 1/20 0.35
FLT3 P36888 1/20 0.35
ALKBH1 Q13686 1/20 0.34
PPARD Q03181 1/20 0.34
PPARA Q07869 1/20 0.34
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIN2B Q13224 1/20 0.34
GRIN2C Q14957 1/20 0.34
GRIN3A Q8TCU5 1/20 0.34
CHEK2 O96017 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9071805 0.93 RIPK1 (0.37) KDM4EMAPTPPARGFFAR1FFAR4
Trifluoroacetic Acid SCHEMBL712600 0.91 FAAH (0.38) FFAR1NOS1
Trifluoroacetic Acid SCHEMBL718789 0.89 PDE4A (0.35) KDM4EPPARGFFAR1CHEK2
Trifluoroacetic Acid SCHEMBL711889 0.88 HDAC3 (0.34)
Trifluoroacetic Acid SCHEMBL711504 0.88 NOS1 (0.35) KDM4EMAPTFFAR1NOS1CHEK2
Trifluoroacetic Acid SCHEMBL709575 0.88 SYK (0.34) KDM4EMAPTPPARGFFAR1NOS1
Trifluoroacetic Acid SCHEMBL708256 0.86 GUCY1B2 (0.36) KDM4EPPARG
SCHEMBL711039 0.85 PRMT5 (0.41) MAPTCHEK2
Trifluoroacetic Acid SCHEMBL711518 0.85 PDE4A (0.36) FFAR1NOS1
Trifluoroacetic Acid SCHEMBL709074 0.84 NAMPT (0.36) KDM4EMAPTNOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940837-B1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL (JP) 2012-11-07 EP disclosed
US-8124617-B2 Imidazopyridine compounds TAKEDA SAN DIEGO, INC. (US) 2012-02-28 US disclosed
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA SAN DIEGO, INC. 2010-03-18 US disclosed
EP-1940837-A2 IMIDAZOPYRIDINE COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2008-07-09 EP disclosed
WO-2007028135-A2 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS GCK, GCKR, KHK KDM4E 1923/4885MAPT 3003/4885PPARG 991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.